drugset / Trial / NCT01068561
Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the short-term safety of a single intravitreal injection of autologous bone marrow stem cells in patients with retinitis pigmentosa.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-01
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous bone marrow stem cells | Cell therapy | 1e+07 cells | Intravitreal |